PMVP insider filings

PMV Pharmaceuticals, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-10-05. Screen PMVP transaction legs live →

Insider transaction summary — last 90 days

2026-08-23 to 2026-11-21, from the filings listed below: 2 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By insider — same window

Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

InsiderFilingsPurchases (P)Sales (S)Other legs
Eckler Matthew Joseph — Director2——1

Recent insider filings — PMV Pharmaceuticals, Inc.

FiledFormInsiderReported transactionsSource
2026-10-054Eckler Matthew Joseph — DirectorGrant/award (A): 84,000 (derivative) @ $0EDGAR
2026-10-053Eckler Matthew Joseph — DirectorHoldings only — no transactions reportedEDGAR
2026-06-054FLOWERS KIRSTEN — DirectorGrant/award (A): 42,000 (derivative) @ $0EDGAR
2026-06-054Stelzer Laurie — DirectorGrant/award (A): 42,000 (derivative) @ $0EDGAR
2026-06-054BAUM CHARLES M — DirectorGrant/award (A): 42,000 (derivative) @ $0EDGAR
2026-06-054Gallagher Carol Giltner — DirectorGrant/award (A): 42,000 (derivative) @ $0 · Gift (G): 42,000 (derivative) @ $0 · Gift (G): 42,000 (derivative) @ $0EDGAR
2026-06-054LEVINE ARNOLD J — DirectorGrant/award (A): 42,000 (derivative) @ $0EDGAR
2026-03-094Carulli Michael — Chief Financial OfficerGrant/award (A): 240,000 (derivative) @ $0EDGAR
2026-03-094Jalota Deepika — Chief Development OfficerGrant/award (A): 303,310 (derivative) @ $0EDGAR
2026-03-094Ticktin Robert — General Counsel & COOGrant/award (A): 319,270 (derivative) @ $0EDGAR
2026-03-094Mack David Henry — President and CEO, DirectorGrant/award (A): 744,960 (derivative) @ $0EDGAR
2025-10-294Mack David Henry — President and CEO, DirectorOption exercise (M): 220,643 @ $1.37 · Option exercise (M): 220,643 (derivative) @ $0EDGAR
2025-10-274ORBIMED ADVISORS LLC — 10% owner
OrbiMed Capital GP V LLC — 10% owner
Sale (S): 1,000,000 @ $1.52EDGAR
2025-09-124ORBIMED ADVISORS LLC — 10% owner
OrbiMed Capital GP V LLC — 10% owner
Sale (S): 500,000 @ $1.80EDGAR
2025-07-034Jalota Deepika — Chief Development OfficerSale (S): 33,065 @ $1.06EDGAR
2025-07-034Carulli Michael — Chief Financial OfficerSale (S): 28,249 @ $1.06EDGAR
2025-07-034Ticktin Robert — General Counsel & COOSale (S): 23,151 @ $1.06EDGAR
2025-07-034Mack David Henry — President and CEO, DirectorSale (S): 58,411 @ $1.06EDGAR
2025-06-094FLOWERS KIRSTEN — DirectorGrant/award (A): 33,500 (derivative) @ $0EDGAR
2025-06-094Stelzer Laurie — DirectorGrant/award (A): 33,500 (derivative) @ $0EDGAR
2025-06-094Heyman Richard A. — DirectorGrant/award (A): 33,500 (derivative) @ $0EDGAR
2025-06-094BAUM CHARLES M — DirectorGrant/award (A): 33,500 (derivative) @ $0EDGAR
2025-06-094Gallagher Carol Giltner — DirectorGrant/award (A): 33,500 (derivative) @ $0 · Gift (G): 33,500 (derivative) @ $0 · Gift (G): 33,500 (derivative) @ $0EDGAR
2025-06-094LEVINE ARNOLD J — DirectorGrant/award (A): 33,500 (derivative) @ $0EDGAR
2025-03-054Carulli Michael — Chief Financial OfficerGrant/award (A): 265,000 (derivative) @ $0EDGAR
2025-03-054Jalota Deepika — Chief Development OfficerGrant/award (A): 300,000 (derivative) @ $0EDGAR
2025-03-054Mack David Henry — President and CEO, DirectorGrant/award (A): 800,000 (derivative) @ $0EDGAR
2025-01-224Mack David Henry — President and CEO, DirectorOption exercise (M): 91,750 @ $0.53 · Option exercise (M): 17,709 @ $0.53 · Option exercise (M): 91,750 (derivative) @ $0 · Option exercise (M): 17,709 (derivative) @ $0EDGAR
2024-10-034Jalota Deepika — Chief Development OfficerDisposition to issuer (D): 22,674 (derivative) · Disposition to issuer (D): 68,100 (derivative) · Grant/award (A): 90,774 (derivative) · Disposition to issuer (D): 125,000 (derivative) · Grant/award (A): 125,000 (derivative)EDGAR
2024-10-034Carulli Michael — Chief Financial OfficerDisposition to issuer (D): 13,605 (derivative) · Disposition to issuer (D): 27,200 (derivative) · Grant/award (A): 40,805 (derivative) · Disposition to issuer (D): 75,000 (derivative) · Grant/award (A): 75,000 (derivative)EDGAR
2024-10-034Mack David Henry — President and CEO, DirectorDisposition to issuer (D): 134,584 (derivative) · Disposition to issuer (D): 249,600 (derivative) · Grant/award (A): 384,184 (derivative) · Disposition to issuer (D): 330,000 (derivative) · Grant/award (A): 330,000 (derivative)EDGAR
2024-09-124Jalota Deepika — Chief Development OfficerSale (S): 7,218 @ $1.50EDGAR
2024-09-124Carulli Michael — Chief Financial OfficerSale (S): 2,891 @ $1.50EDGAR
2024-06-104FLOWERS KIRSTEN — DirectorGrant/award (A): 67,500 (derivative) @ $0EDGAR
2024-06-104Stelzer Laurie — DirectorGrant/award (A): 67,500 (derivative) @ $0EDGAR
2024-06-104Heyman Richard A. — DirectorGrant/award (A): 67,500 (derivative) @ $0EDGAR
2024-06-104BAUM CHARLES M — DirectorGrant/award (A): 67,500 (derivative) @ $0EDGAR
2024-06-104Gallagher Carol Giltner — DirectorGrant/award (A): 67,500 (derivative) @ $0 · Gift (G): 67,500 (derivative) @ $0 · Gift (G): 67,500 (derivative) @ $0EDGAR
2024-06-104LEVINE ARNOLD J — DirectorGrant/award (A): 67,500 (derivative) @ $0EDGAR
2024-01-224Jalota Deepika — Chief Development OfficerGrant/award (A): 95,555 @ $0 · Grant/award (A): 225,095 (derivative) @ $0EDGAR
2024-01-224Carulli Michael — Chief Financial OfficerGrant/award (A): 82,220 @ $0 · Grant/award (A): 204,630 (derivative) @ $0EDGAR
2024-01-224Mack David Henry — President and CEO, DirectorGrant/award (A): 163,890 @ $0 · Grant/award (A): 519,915 (derivative) @ $0EDGAR
2023-11-244ORBIMED ADVISORS LLC — 10% owner
OrbiMed Capital GP V LLC — 10% owner
OrbiMed Genesis GP LLC — 10% owner
Sale (S): 87,786 @ $2.23EDGAR
2023-11-134Mack David Henry — President and CEO, DirectorOption exercise (M): 198,407 @ $0.53 · Gift (G): 85,307 @ $0 · Gift (G): 85,307 @ $0 · Option exercise (M): 198,407 (derivative) @ $0EDGAR
2023-09-184Jalota Deepika — Chief Development OfficerSale (S): 4,104 @ $6.62EDGAR
2023-09-184Alland Leila — Chief Medical OfficerSale (S): 6,291 @ $6.62EDGAR
2023-08-084Mack David Henry — President and CEO, DirectorOption exercise (M): 85,500 @ $0.53 · Option exercise (M): 85,500 (derivative) @ $0EDGAR
2023-06-124BAUM CHARLES M — DirectorGrant/award (A): 21,500 (derivative) @ $0EDGAR
2023-06-124Gallagher Carol Giltner — DirectorGrant/award (A): 21,500 (derivative) @ $0 · Gift (G): 21,500 (derivative) @ $0 · Gift (G): 21,500 (derivative) @ $0EDGAR
2023-06-124LEVINE ARNOLD J — DirectorGrant/award (A): 21,500 (derivative) @ $0EDGAR

Recent 8-K events — PMV Pharmaceuticals, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-208-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-11-108-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-10-058-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-09-028-K1.01 — Entry into a Material Definitive Agreement
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-318-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-148-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-058-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2026-05-128-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-068-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2025-11-128-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=PMVP returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs